| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other comprehensive loss | -19 | -4,264 | -2,013 | -1,713 |
| Comprehensive loss | -48,240 | -42,537 | -38,651 | -32,516 |
| Net loss per share, basic (in dollars per share) | -0.21 | -0.17 | -0.16 | -0.14 |
| Net loss per share, diluted (in dollars per share) | -0.21 | -0.17 | -0.16 | -0.14 |
| Weighted average common shares outstanding, basic (in shares) | 227,981,475 | 227,275,466 | 226,818,051 | 226,346,058 |
| Weighted average common shares outstanding, diluted (in shares) | 227,981,475 | 227,275,466 | 226,818,051 | 226,346,058 |
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)